Cost Effectiveness of Romiplostim for the Treatment of Immune Thrombocytopenia (Itp) Patients In the Czech Republic
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.1696
https://www.valueinhealthjournal.com/article/S1098-3015(14)03626-2/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1169
First Page :
A533
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03626-2&doi=10.1016/j.jval.2014.08.1696